Assessment of Treatment Response Following Yttrium-90 Transarterial Radioembolization of Liver Malignancies
Open Access
- 29 June 2018
- journal article
- review article
- Published by Springer Nature in Cureus
- Vol. 10 (6) , e2895
Abstract
Transarterial radioembolization using yttrium-90 microspheres is an established and effective treatment for liver malignancies. Determining response to this treatment is difficult due to the radical changes that occur in tissue as a response to radiation. Though accurate assessment of treatment response is paramount for proper patient disposition, there is currently no standardized assessment protocol. Current methods of assessment often consider changes in size, necrosis, vascularity, fluorodeoxyglucose-positron emission tomography FDG-PET metabolic activity, and diffusion using diffusion-weighted magnetic resonance imaging (DWI). Current methods of assessment require a lag time of one to two months post-treatment to determine treatment effectiveness. This delay is a hindrance to obtaining better patient outcomes, giving rise to a need to identify markers for faster determination of treatment efficacy.Keywords
This publication has 26 references indexed in Scilit:
- Radiodosimetric Estimates for Radioembolic Therapy of Liver Tumors: Challenges and OpportunitiesJournal of Nuclear Medicine, 2012
- Imaging characteristics following 90yttrium microsphere treatment for unresectable liver cancerJournal of Medical Imaging and Radiation Oncology, 2011
- Morphologic and Functional Changes in Nontumorous Liver Tissue After Radiofrequency Ablation in an In Vivo Model: Comparison of 18F-FDG PET/CT, MRI, Ultrasound, and CTJournal of Nuclear Medicine, 2007
- Response of Liver Metastases After Treatment with Yttrium-90 Microspheres: Role of Size, Necrosis, and PETAmerican Journal of Roentgenology, 2007
- Imaging of Hepatocellular Carcinoma After Treatment with Yttrium-90 MicrospheresAmerican Journal of Roentgenology, 2007
- Functional MR Imaging Assessment of Tumor Response after 90Y Microsphere Treatment in Patients with Unresectable Hepatocellular CarcinomaJournal of Vascular and Interventional Radiology, 2007
- Radioembolization with 90Yttrium Microspheres: A State-of-the-Art Brachytherapy Treatment for Primary and Secondary Liver MalignanciesJournal of Vascular and Interventional Radiology, 2006
- Diffusion-weighted MR Imaging for Determination of Hepatocellular Carcinoma Response to Yttrium-90 RadioembolizationJournal of Vascular and Interventional Radiology, 2006
- Epidemiology of Primary and Secondary Liver CancersSeminars in Interventional Radiology, 2006
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000